Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicure Inc
V.MPH
Alternate Symbol(s):
MCUJF
Healthcare
Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United...
States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(0)
•••
Claude5555
X
View Profile
View Bullboard History
Post by
Claude5555
on Apr 23, 2024 6:52pm
Medicure Receives US FDA Fast Track Designation for MC-1
WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization
...more
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Dec 14, 2023 5:44pm
watch the video at the bottom of the page
for a good synopsis of Medicure. You heard it here first. This is a $6 dollar stock. https://www.medicure.com/albert-friesen-bam-leadership-award
Fresh Insight into the Topaz Helium Project's Expected Size and Scale
posted Apr 26, 2024 9:00am by
Pulsar Helium Inc.
-
|
The prospective zone is very broad. We believe its not just an isolated occurrence but is actually something quite regionally extensive ...read more
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Dec 14, 2023 5:05pm
we are led by greatness
https://mailchi.mp/273b3f090d3a/a-dr-albert-friesen-receives-2023-outstanding-leadership-in-bioscience-award?e=d7939b6781
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 05, 2023 5:02pm
New Press Release - Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
WINNIPEG, MB / ACCESSWIRE / December 5, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, through its...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 23, 2023 5:01pm
New Press Release - Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
WINNIPEG, MB / ACCESSWIRE / November 23, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 21, 2023 5:01pm
New Press Release - Medicure Reports Financial Results for Quarter Ended September 30, 2023
WINNIPEG, MB / ACCESSWIRE / November 21, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported...
read article.
(7)
•••
pholover
X
View Profile
View Bullboard History
Comment by
pholover
on Nov 15, 2023 2:48pm
RE:are you ever out of date
Please identify which statements were false? It was apparent from reading the Financial Statements that they were behind in Royalties but that looks to be cleared up...but show me where the
...more
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Nov 15, 2023 10:04am
are you ever out of date
obviously you have not been following the company and making false statements because you lost money in the past. Get over it. We have great management, a great team, and great prospects in the future
...more
(7)
•••
pholover
X
View Profile
View Bullboard History
Comment by
pholover
on Nov 13, 2023 1:32pm
RE:RE:RE:RE:a couple of jokers with no cents, non sense etc
No debt is a good thing. However, No long term profitabiltiy and Management keeps stepping in it (CEO bought a 10 Million Dollar chunk of a company that became worthless the same year
...more
(23)
•••
Checkout
X
View Profile
View Bullboard History
Comment by
Checkout
on Nov 13, 2023 11:04am
RE:RE:RE:a couple of jokers with no cents, non sense etc
why dont you call the company and ask them if your so interested in a correct answer to your insinuating question. Here are 6 reasons to invest in Medicure: Profitable and growing profit
...more
(7)
•••
pholover
X
View Profile
View Bullboard History
Comment by
pholover
on Oct 30, 2023 3:34pm
RE:RE:a couple of jokers with no cents, non sense etc
For the last three years I can not find any payments for Zypitimag that were due under the terms and there is no disclosure of breach of terms in the FS. Can anyone find where these
...more
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Oct 06, 2023 10:07am
And if MC1 works well in tablets, in all likelihood
it will work better/faster crushed.
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Oct 06, 2023 10:04am
not enough for the two bash turding this stock, 200m
passed in 2012, the FDA grants a Rare Pediatric Disease Designation for serious and life threatening diseases that primarily affect children. If a new drug application for MC1 for patients with PNPO
...more
(0)
•••
rizeresp
X
View Profile
View Bullboard History
Comment by
rizeresp
on Oct 04, 2023 2:57pm
RE:a couple of jokers with no cents, non sense etc
definitely nice too see a new 52 week high today. Wonder if insiders are still accumulating.
(23)
•••
Checkout
X
View Profile
View Bullboard History
Post by
Checkout
on Oct 04, 2023 1:09pm
a couple of jokers with no cents, non sense etc
this is a $6 stock once MC1 demontstrates it works as well in crushed form as it does in tablets. 100 million cash. 6 Reasons to Invest in Medicure (mailchi.mp)
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil